Cargando…
Revising the WHO Essential Medicines List for paediatric rheumatology update
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569128/ https://www.ncbi.nlm.nih.gov/pubmed/36241998 http://dx.doi.org/10.1186/s12969-022-00752-0 |
_version_ | 1784809795287515136 |
---|---|
author | Slamang, Waheba Smith, Nicola Scott, Chris Foster, Helen |
author_facet | Slamang, Waheba Smith, Nicola Scott, Chris Foster, Helen |
author_sort | Slamang, Waheba |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9569128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95691282022-10-16 Revising the WHO Essential Medicines List for paediatric rheumatology update Slamang, Waheba Smith, Nicola Scott, Chris Foster, Helen Pediatr Rheumatol Online J Letter to the Editor BioMed Central 2022-10-14 /pmc/articles/PMC9569128/ /pubmed/36241998 http://dx.doi.org/10.1186/s12969-022-00752-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Slamang, Waheba Smith, Nicola Scott, Chris Foster, Helen Revising the WHO Essential Medicines List for paediatric rheumatology update |
title | Revising the WHO Essential Medicines List for paediatric rheumatology update |
title_full | Revising the WHO Essential Medicines List for paediatric rheumatology update |
title_fullStr | Revising the WHO Essential Medicines List for paediatric rheumatology update |
title_full_unstemmed | Revising the WHO Essential Medicines List for paediatric rheumatology update |
title_short | Revising the WHO Essential Medicines List for paediatric rheumatology update |
title_sort | revising the who essential medicines list for paediatric rheumatology update |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569128/ https://www.ncbi.nlm.nih.gov/pubmed/36241998 http://dx.doi.org/10.1186/s12969-022-00752-0 |
work_keys_str_mv | AT slamangwaheba revisingthewhoessentialmedicineslistforpaediatricrheumatologyupdate AT smithnicola revisingthewhoessentialmedicineslistforpaediatricrheumatologyupdate AT scottchris revisingthewhoessentialmedicineslistforpaediatricrheumatologyupdate AT fosterhelen revisingthewhoessentialmedicineslistforpaediatricrheumatologyupdate AT revisingthewhoessentialmedicineslistforpaediatricrheumatologyupdate |